Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,112
Total Claims
$204K
Drug Cost
405
Beneficiaries
$504
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+37%
Opioid rate vs peers
62.9% vs 45.9% avg
+4%
Cost per patient vs peers
$504 vs $483 avg
-36%
Brand preference vs peers
2.7% vs 4.1% avg
Opioid Prescribing
62.9%
Opioid Rate
3,213
Opioid Claims
$134K
Opioid Cost
16.1%
Long-Acting Rate
This provider's opioid prescribing rate of 62.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 136 claims · $58K
Generic: 4,976 claims · $146K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 979 | $45K |
| Hydrocodone/Acetaminophen | 775 | $22K |
| Oxycodone Hcl | 813 | $18K |
| Morphine Sulfate | 433 | $13K |
| Buprenorphine | 13 | $13K |
| Oxycodone Myristate | 22 | $11K |
| Linaclotide | 14 | $11K |
| Lidocaine | 15 | $9,344 |
| Gabapentin | 388 | $8,481 |
| Pregabalin | 270 | $7,902 |
| Naloxegol Oxalate | 13 | $7,192 |
| Tizanidine Hcl | 235 | $4,894 |
| Hydrocodone/Ibuprofen | 12 | $4,753 |
| Diclofenac Sodium | 85 | $4,514 |
| Fentanyl | 42 | $4,414 |
Prescribing Profile
30
Unique Drugs
12.0
Anomaly Score
Patient Profile
67
Avg Age
63%
Female
1.97
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About